Carboplatin Plus Gemcitabine for Elderly Patients With Stage IV NSCLC
Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
The investigators propose to study the safety and efficacy of the combination of Carboplatin
plus Gemcitabine in a Phase I/II trial of elderly subjects with non-small cell lung cancer.